Hit to lead: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 13:54, 17 March 2025
Hit to Lead (H2L) is a process in Drug Discovery and Pharmacology that involves the identification of active, but chemically simple compounds, and their subsequent refinement into more potent and selective chemical entities. This process is a critical step in the development of new Medicinal Drugs.
Overview[edit]
The Hit to Lead process begins with the identification of a 'hit', a compound that demonstrates some level of activity against a chosen Biological Target. This hit is typically identified through High-Throughput Screening (HTS) of large libraries of compounds. Once a hit has been identified, it is then optimized through a process of Medicinal Chemistry to improve its potency, selectivity, and pharmacokinetic properties. This optimized compound is known as a 'lead'.
Hit Identification[edit]
Hit identification is the first step in the Hit to Lead process. This involves the screening of large libraries of compounds against a chosen biological target. The aim of this step is to identify compounds that show some level of activity against the target. This is typically achieved through the use of High-Throughput Screening (HTS), a process that allows for the rapid testing of large numbers of compounds.
Lead Optimization[edit]
Once a hit has been identified, it is then optimized to improve its potency, selectivity, and pharmacokinetic properties. This is achieved through a process of Medicinal Chemistry, which involves the systematic modification of the hit compound's chemical structure. The aim of this process is to produce a 'lead' compound that is suitable for further development.
Challenges[edit]
The Hit to Lead process is not without its challenges. One of the main challenges is the need to balance potency and selectivity with acceptable pharmacokinetic properties. This often requires a process of iterative design and testing, which can be time-consuming and costly. Additionally, the process is often complicated by the need to consider potential Toxicity and Side Effects of the lead compound.
See Also[edit]
